Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Acadia Pharmaceuticals Inc.

Clinical trials sponsored by Acadia Pharmaceuticals Inc., explained in plain language.

Acadia Pharmaceuticals Inc. ACAD NASDAQ

A biopharmaceutical company developing treatments for central nervous system disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 4 Terminated 1

Autism irritability drug trial ends early: what happened?

Symptom relief Terminated

This study looked at the long-term safety of pimavanserin for treating irritability in children and teens (ages 5-17) with autism. It was an extension of an earlier 6-week study, lasting 52 weeks. The trial was terminated early, and results are not yet fully available.

Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 08:01 UTC